Janssen Biotech, Inc. has announced the launch of Gut Check™, a new platform to help improve disease monitoring for the 1.6 million Americans living with Crohn's disease and ulcerative colitis, collectively known as inflammatory bowel diseases (IBD). Gut Check™ offers a mobile application for patients and a dashboard for healthcare professionals, designed to enhance communication between patients and their HCPs.
With Gut Check™, people living with IBD can track their daily symptoms and lifestyle habits via the mobile application and share this information in real-time with their healthcare professionals (HCPs). The application leverages bi-weekly patient-reported outcome surveys (PROMIS) validated by the National Institute of Health to help assess progress over time. HCPs can use Gut Check™ to view their patients' data through a HIPAA-compliant dashboard on their tablet or computer. Using the dashboard, they can filter and compare patient data within their practice, local data and national data.
"From my experience, people living with IBD often underreport their symptoms – they tend to focus on how they have been feeling the past few days versus the past few months," said Dr. Ralph McKibbin, gastroenterologist, Blair Gastroenterology Associates. "Early intervention is key when it comes to caring for IBD. New platforms like Gut Check™ will help me to more closely monitor my patients in real-time."
Additional GutCheck™ features for patients include:
- Bi-weekly, NIH -validated PROMIS® surveys to help track patients' symptoms and progress over time
- Health Tracker for patients to monitor their daily well-being
- A GPS-enabled bathroom finder, complete with ratings and reviews
- Ability to share activity and engagement via social media channels
- Informative tips on IBD-related topics, including diet and exercise
- An integrated calendar to organize appointments and local IBD community events
- Tokens and comparative status ranking earned through engagement
"Managing IBD is a significant challenge, and improving the efficiency and timeliness of communication between patients and healthcare professionals is critical in providing optimal care," said Andrew Greenspan, M.D., vice president of medical affairs at Janssen Biotech, Inc. "We created Gut Check™ to enable real-time communication between healthcare professionals and patients, with the ultimate goal of enabling HCPs to more closely monitor disease progression."
The Gut Check™ application is free for individuals living with IBD, and the Gut Check™ dashboard (to connect with patients) is free for healthcare professionals. Gut Check™ is now available in the Apple App Store® and Google Play®. For more information, visit www.gutcheckapp.com.